HighTide Therapeutics Inc HTTIF
$0.39
Last Updated: Jun 30, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
HighTide Therapeutics Inc. Stock Analysis HTTIF
United States Health Care Micro Cap Hightide Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for people suffering from non-viral chronic liver diseases, gastrointestinal diseases, and metabolic disorders with large and unsatisfied market needs. The company is headquartered in Shenzhen, Guangdong and currently employs 51 full-time employees. The company went IPO on 2023-12-22. The firm has developed a product pipeline of multiple product candidates in-house, covering many indications in metabolic and digestive diseases among which, some are at clinical-stage. The Company’s core product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases. The firm conducts operations in the United States, Mainland China, Hong Kong and Australia.
HighTide Therapeutics Inc (HTTIF) Chart
Financial Metrics & Statements of HighTide Therapeutics Inc (HTTIF)
FAQ's for HighTide Therapeutics Inc (HTTIF)
- As of August 2026, HighTide Therapeutics Inc HTTIF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes HighTide Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in HighTide Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of HighTide Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of HighTide Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of HighTide Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for HighTide Therapeutics Inc (HTTIF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
